These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29389238)

  • 1. Inflammatory Diseases of the Gut.
    Rohr M; Narasimhulu CA; Sharma D; Doomra M; Riad A; Naser S; Parthasarathy S
    J Med Food; 2018 Feb; 21(2):113-126. PubMed ID: 29389238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet in the pathogenesis and treatment of inflammatory bowel diseases.
    Lee D; Albenberg L; Compher C; Baldassano R; Piccoli D; Lewis JD; Wu GD
    Gastroenterology; 2015 May; 148(6):1087-106. PubMed ID: 25597840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets.
    Yadav V; Varum F; Bravo R; Furrer E; Bojic D; Basit AW
    Transl Res; 2016 Oct; 176():38-68. PubMed ID: 27220087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.
    El-Salhy M; Solomon T; Hausken T; Gilja OH; Hatlebakk JG
    World J Gastroenterol; 2017 Jul; 23(28):5068-5085. PubMed ID: 28811704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of IBD associated diarrhea.
    Anbazhagan AN; Priyamvada S; Alrefai WA; Dudeja PK
    Tissue Barriers; 2018; 6(2):e1463897. PubMed ID: 29737913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
    Seo JK; Yeon KM; Chi JG
    J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal motility disorders in inflammatory bowel diseases.
    Bassotti G; Antonelli E; Villanacci V; Salemme M; Coppola M; Annese V
    World J Gastroenterol; 2014 Jan; 20(1):37-44. PubMed ID: 24415856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiota in IBD.
    Manichanh C; Borruel N; Casellas F; Guarner F
    Nat Rev Gastroenterol Hepatol; 2012 Oct; 9(10):599-608. PubMed ID: 22907164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases.
    Sobczak M; Fabisiak A; Murawska N; Wesołowska E; Wierzbicka P; Wlazłowski M; Wójcikowska M; Zatorski H; Zwolińska M; Fichna J
    Pharmacol Rep; 2014 Oct; 66(5):766-75. PubMed ID: 25149979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD).
    El-Salhy M; Hausken T
    Neuropeptides; 2016 Feb; 55():137-44. PubMed ID: 26431932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between selenium and gastrointestinal inflammatory diseases].
    Nagy DT; Fülesdi B; Hallay J
    Orv Hetil; 2013 Oct; 154(41):1636-40. PubMed ID: 24095913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.
    Alhouayek M; Muccioli GG
    Trends Mol Med; 2012 Oct; 18(10):615-25. PubMed ID: 22917662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
    Serban DE
    Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms.
    Engelhardt KR; Grimbacher B
    Curr Top Microbiol Immunol; 2014; 380():1-18. PubMed ID: 25004811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches.
    Abraham BP; Ahmed T; Ali T
    Handb Exp Pharmacol; 2017; 239():115-146. PubMed ID: 28233184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.